At least four horrifically botched executions last year — in Ohio, Oklahoma, and Arizona — heightened public alarm at the risk of unusual methods of capital punishment in the US.
What made 2014 such a problematic year for capital punishment? One reason was due to chronic drug shortages.
When European pharmaceutical companies stopped selling execution drugs to the US after they found out what their drugs were being used for, states turned to drugs that have never been used before in executions, and are not approved by the FDA.
KQ/HJL